Furthermore, some of the prepared products were selected and tested for activity against HCT116 and MCF-7 (human colon carcinoma and human breast carcinoma).
INTRODUCTION
Fused thiazolo [4,5-d] 
RESULTS AND DISCUSSION
With respect to the previous studies carried out in our laboratory, 2-thioxopyrimidine derivative 1, precurosors (Takeshima, et al., 1968) have been regarded as promising intermediates to produce thiazolopyrido pyrimidin-2,4-dithione derivatives 5,a,b and thiazolo [4,5-d] pyrimidin-2-thione derivatives 6a-c which bear some structural analogies with natural nucleobases. The interaction of pyrimidin-2-thione derivative 1 with chloroacetic acid and aromatic aldehydes in the presence of acetic anhydride (Hamman, et al., 1981) led to the formation of 2-(arylmethylene) trimethylthiazolidino[3,2-a]pyrimidin-3-one 2a-c (Scheme 1). The structures of compounds 2a-c were deduced from elemental analysis and spectral data. Compound 2b as an example: its IR spectrum showed absorption band at 1706cm -1 (υ CO ); moreover, 1 H NMR spectrum showed signals at 7.36 ppm (s, 1H,=CH-Ar) and 7.80-7.99 (m, 4H, ArH).
Interaction of compound 2a,b with malononitrile in acetic acid in the presence of ammonium acetate under reflux led to the formation of enaminonitrile derivatives 3a,b (Scheme 1). The IR spectrum of compound 3a showed the presence of bands characteristic for a cyano group at 2193cm -1 and amino group at 3209 & 3344 cm -1 . The pyrimidin-2,4-dithione derivatives 5a,b were obtained by refluxing of 3a,b with carbon disulfide in dry pyridine (Hefez, et al. 2010) as shown in (Scheme 1). The proposed structure was confirmed by spectral data. The IR spectrum of 5a revealed the absence of a band characteristic for the cayno group, moreover, the 13 C NMR spectrum showed signal at  176.13 & 176.87 ppm corresponding to the two thione groups. 
Scheme 2
The structures of these compounds were confirmed with elemental analysis and spectral data. Compound 6a as an example: its IR spectrum showed absorption bands at 3166.8 and 3273.8 cm -1 (2NH); 13 C NMR spectrum of 6b revealed the presence of (C=S) at 173.43 ppm. Compounds 6a-c were found to be useful for the syntheses of the interesting [1,2,4]triazolopyrimidines. Thus , two possible pathways can be accounted for the formaiotn of compound 10:1). the 1,3-dipolar cycloaddition of the thiol tautomer 6 to the nitrilium imide, generated in situ from hydrazonyl halides and triethylamine in dry chloroform gave the thiohydrazonate ester 7 which underwent nucleophilic cyclization to yield the spiro compound 8 followed by opening ring to give 9 which cyclized to yield 10 by loss of hydrogen sulfide: 2)1,3-dipolar cycloaddition of the nitrilium imide to the C=S double bond of 6 can give hydrazontester 11 which then cyclized to give intermediate 12 which in turn gave compound 10 by loss of hydrogen sulfide (scheme 2). All attempts to isolate any intermediates were unsuccessful. Structures of 10a,b were elucidated on the basis of elemental analysis, spectral data and alternative synthetic route E tO H ,p ip ,
Scheme (3)
On the other hand, alkylation of compound 6b with chloroacetyl chloride in the presence of triethylamine and dimethyl formamide gave 4-(m-nitrophenyl)-7,7,9-trimethyl-
ethanethioate (17). Dehydrohalogenation took place joining two molecules of compound 6b. Inspection of the IR spectrum of the reaction product 17 revealed the presence of the C=O group and its mass spectrum exhibited a molecular ion peak M + at m/z: 814 (12.7%) (c.f. Experimental).
PHARMACOLOGY

Antitumor effect
CONCLUSION
The newly synthesized compounds 2b and 13 were tested for antitumor activity and they exhibited a high significant anticancer activity against both of HCT 116cell line and MCF-7 cell line (human colon carcinoma cell and human breast carcinoma cell). The results are summarized in Figures. 1-4 
Comment:
Inhibitory activity against breast carcinoma cells was detected under these experimental conditions with IC 50 = 2.4 µg. 
EXPERIMENTAL
Melting points were recorded on an electrothermal IA 9100 digital melting point apparatus and were uncorrected. IR spectra (V max in cm -1 ) were recorded on a Shimadzu FT-IR 8300 spectrophotometer using KBr pellets technique.
1 H-NMR and 13 C-NMR spectra were recorded using Bruker WM-400 spectrophotometer using DMSO-d 6 as the solvent and TMS as the internal reference (chemist shifts in ppm). The mass spectra were run at 70 eV with a finnigan SSQ7000 spectrophotometer (thermo-instrument system incorporation, USA) Elemental analysis were operated using Mario El Mentar apparatus, Organic microanalysis unit. Elemental analysis and the above spectra were measured the at National Research Center. Pharmacology was carried out in the Regional Center for Mycology & Biotechnology, Al-Azhar University.
2-Arylidine-5,7,7-trimethyl thiazolidino[3,2-a]pyrimidin-3-one (2a-c).
General procedure: A mixture of compound 1 (0.01 mol), chloroacetic acid (0.01 mol), aromatic aldehyde (0.01 mol) and 2 gm of fused sodium acetate in 10 mL of acetic acid and 5 mL of acetic anhydride was refluxed for 1h . The reaction mixture was allowed to cool and then poured into cold water, the product obtained was filtered, dried and recrystalized from the proper solvent to give 2a-c.
2-(p-Bromobenzylidine)-5,7,7-trimethyl thiazolidino[3,2-a] pyrimidine-3-one (2a).
It was obtained from 1 and p-bromobenzaldehyde; IR (cm -1 , ): 1703 (CO); 1 H-NMR (DMSO-d 6 , δ, ppm): 1.31, 1.37,1.69 (3s, 9H, C -7 2CH 3 , C -5 CH 3 ), 5.19 (s, 1H, C -6 H), 7.41-7.81(m, 5H, 1H=CH-+ 4HArH).
2-(m-Nitrobenzylidine)-5,7,7-trimethyl thiazolidino[3,2-a]pyrimidin 3-one (2b)
It was obtained from compound 1 and m-nitrobenzaldehyde; IR (cm -1 , υ) 1706(CO); 1 H-NMR (DMSO-d 6 , δ, ppm): 1.46, 1.50, 1.78 (3s, 9H,C -7 2CH 3 , C -5 CH 3 ), 5.7 (s, 1H, C -6 H), 7.36 (s, 1H, =CH-Ar), 7.80-7.99 (m, 4H, Ar-H). 
2-(o-
General procedure:
A mixture of compound 2a or 2b (0.01 mol), malononitrile (0.01 mol) and ammonium acetate (0.02 mol) in glacial acetic acid (30 mL) was heated under reflux for 6h., left at room-temperature, then poured into cold water. The solid product was filtered off, washed with water, dried and recrystallized to give compound 3a,b. -4-(p-bromophenyl) Substituted -8,8,10-trimethyl pyrimidino[1'',2'':3',2'] thiazolo[4',5': 2,3]pyrido[2,3-d]  pyrimidin-2,4-[1H, 3H]dithione derivatives (5a,b) .
2-Amino
5-
General procedure: To a solution of o-aminonitrile 3a or 3b (0.01 mol) in pyridine (15 mL), carbon disulfide (0.05 mol) was added and the reaction mixture was heated on a water bath for 10h. After cooling, ethanol was added and the separated solid was collected by filtration, dried and recrystallized to give compound 5a,b . General procedure: A mixture of compound 2a-c (0.01 mol) and thiourea (0.01 mol) was refluxed in absolute ethanol 30 mL and 5 mL of concentration hydrochloric acid for 6h. The solid product was filtered off dried and recrystallized to give compounds 6a-c. 123.76, 124.76, 125.39, 126.72, 128.01, 128 .09 (ArC),128.31(C -4 ) 128.54 (C -4a ), 128.82(C -5a ), 130.25 (C-4b ), 131.18 (C -9 ), 173.43 (C=S). Chlorophenyl)-7,7,9-trimethyl-1,3,4- A solution of compound 6b (0.01 mol) and sodium hydroxide (0.01 mol) in ethanol (30 mL) was treated with 2-chloroethanol (0.01 mol) and the reaction mixture was refluxed for 16h. the formed precipitate was filtered off, dried and recrystalized to give compound A mixture of compound 6b (0.01 mol), acrylonitrile (0.01 mol) and triethylamine two drops in ethanol (50 mL) was heated under reflux for 3h, cooled, filtered, dried and recrystallized to give compound 14. 
5-(p-
4-(p-
Bromophenyl
4-(o-
Synthesis of compounds 15 and 16
Compound 6b (0.01 mol) and salicyladehyde or 7-hydroxy-5-methoxy-2-oxobenzopyran-6-carboxaldehyde (0.01 mol) were refluxed in ethanolic piperidine (30 ml) for 30 min. The solid product was filtered, dried and recrystalized to give compounds 15 and 16. 
Cytotoxicity assay:
The cells were propagated in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% heat-inactivated fetal bovine serum, 1% L-glutamine, HEPES buffer and 50ug/ml gentamycin. All cells were maintained at 37°C in a humidified atmosphere with 5% CO 2 and were subcultured two times a week.
Cell toxicity was monitored by determining the effect of the test samples on cell morphology and cell viability.
Cytotoxicity evaluation using viability assay: For cytotoxicity assay, the cells were seeded in 96-well plate at a cell concentration of 1x 10 4 cells per well in 100µl of growth medium. Fresh medium containing different concentrations of the test sample was added after 24 h of seeding. Serial two-fold dilutions of the tested chemical compound were added to confluent cell monolayers dispensed into 96-well, flat-bottomed microtiter plates (Falcon, NJ, USA) using a multichannel pipette. The microtiter plates were incubated at 37°C in a humidified incubator with 5% CO 2 for a period of 48 h. Three wells were used for each concentration of the test sample. Control cells were incubated without test sample and with or without DMSO. The little percentage of DMSO present in the wells (maximal 0.1%) was found not to affect the experiment. After incubation of the cells for 24 h at 37°C, various concentrations of sample (50, 25, 12.5, 6.25, 3.125 & 1.56 \ig) were added, and the incubation was continued for 48 h and viable cells yield was determined by a colorimetric method.
In brief, after the end of the incubation period, media were aspirated and the crystal violet solution (1%) was added to each well for at least 30 minutes. The stain was removed and the plates were rinsed using tap water until all excess stain is removed. Glacial acetic acid (30%) was then added to all wells and mixed thoroughly, and then the absorbance of the plates were measured after gently shaken on Microplate reader (TECAN, Inc.), using a test wavelength of 490 nm. All results were corrected for background absorbance detected in wells without added stain. Treated samples were compared with the cell control in the absence of the tested compounds. All experiments were carried out in triplicate. The cell cytotoxic effect of each tested compound was calculated (Mosmann, 1983; Vijayan et al., 2004).
